IVI in the Media

South China Morning Post | The latest coronavirus boosters target Omicron. Are they safe and effective?

Financial News | IVI Director General Jerome Kim: ‘Bill Gates a strong advocate of IVI’

South China Morning Post | Scientists urge people to take second Covid vaccine booster if offered as Omicron continues to spread

Financial Times | Unvaccinated and unprepared, North Korea faces Covid catastrophe

Chosun Ilbo | Jerome Kim, Director General of International Vaccine Institute, named a distinguished professor at Seoul National University

Financial Times | South Korea downgrades Covid to a ‘Class 2’ disease and removes restrictions

South China Morning Post | China was the world’s biggest Covid-19 vaccine exporter. Not any more

The Wall Street Journal | Despite High Covid-19 Case Counts, Asian Nations Learn to Live With the Virus

Barron’s | China Eases Some Covid Testing Rules. It’s a Targeted Approach to Reduce Impact on the Economy.

CNBC | We need to treat Covid as an endemic pathogen and update vaccines: International Vaccine Institute

Financial Times | Beijing digs in to avoid repeating Hong Kong’s Covid mistakes

The Telegraph | Why China and Hong Kong face a devastating new Covid wave

CGTN | Why is China seeing a surge in COVID-19 cases?

Financial Times | Shanghai teeters on the brink of Covid lockdown

ADB Insight | Year of the Vaccine: The Next Steps for Asia and the Pacific to Combat COVID-19

Fortune | Will we all need fourth COVID vaccine booster shots?

The Telegraph | South Korea abandons its successful test and trace system as omicron cases surge

South China Morning Post | Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?

The Guardian | Cuba leads the world in vaccinating children as young as two against Covid

The Telegraph | Vaccine hesitancy among Taiwan’s elderly mars its pandemic performance and prevents reopening

Director General Jerome Kim on The Alex Salmond Show

South China Morning Post | Which vaccines stop Omicron? Search for data moves from labs to real world

CNBC | 2022 will be the ‘year of vaccination,’ says director of vaccine institute

South China Morning Post | As Omicron upends Covid-19 vaccine targets, what will the future look like?

South China Morning Post | Omicron and the Winter Olympics – is China’s zero-Covid strategy up to the challenges?

CBS Mornings | With Omicron on its doorstep, countries in Asia are closing up

National Geographic | Omicron is dodging the immune system—but boosters show promising signs

Khaleej Times | Covid: 96% of people in low-income nations have yet to receive first vaccine dose, says expert

Voice of America | South Korea Showed How to Contain COVID, Now It Will Try to Live With It

China Daily | Experts say countries should remain cautious about reopening borders

South China Morning Post | Next Covid-19 test? Diagnostic blind spots stir visions of bleak midwinter

South China Morning Post | US-China coronavirus vaccine diplomacy heats up but can donations sway allegiances?

The New York Times | How Asia, Once a Vaccination Laggard, Is Revving Up Inoculations

South China Morning Post | Coronavirus: as rich countries turn to big-name booster shots from Pfizer, AstraZeneca, the poor are left with lesser-known rivals like Abdala, Soberana 2

South China Morning Post | Coronavirus: China seeks to develop next-gen vaccines amid trial complications

South China Morning Post | Can China stay ahead as a leading exporter of Covid-19 vaccines?

Maeil Business Newspaper | All music is beautiful in its own way, but Violinist Sang Hee Lee’s music shines a special light

Nature | Six months of COVID vaccines: what 1.7 billion doses have taught scientists

Asian Boss | We Asked Top Vaccine Expert About COVID Vaccine Problems

Bloomberg | Consequences of ‘Huge’ Global Gap in Vaccinations

EIU Perspectives | What does Denmark’s permanent suspension of both the AstraZeneca and Janssen covid-19 vaccines mean for other countries?

Asia Times | Vaccinations in a race against viral variants

Nature | Why COVID vaccines are so difficult to compare

DEVEX | Opinion: COVAX — too big, and too important, to fail

CNN | “Our response needs to be clear, strong, and unified”

South China Morning Post | Coronavirus vaccines will save 2021? Not so fast, here’s what the experts think

Bloomberg | Will the Covid-19 Vaccines Be Effective and Safe?

Asian Boss | Update On COVID-19 Vaccine Price & Schedule From A Leading Vaccine Expert

The Telegraph | ‘If you are not prepared, the virus has found every weakness’: How countries in Asia tamed Covid-19

CGTN | ‘The vaccine itself is not the silver bullet,’ says International Vaccine Institute

Devex | Q&A: Why Jerome Kim is ‘hopeful’ but cautious about distributing a COVID-19 vaccine

Maeil Business Newspaper | IVI Director General Jerome Kim Shares His Thoughts on Resurgence of COVID-19 Outbreaks in S. Korea

Chosun Ilbo | IVI Director General Jerome Kim Shares His Thoughts on Equitable Access of COVID-19 Vaccines

Channel News Asia | On a fast track like never before: The COVID-19 vaccine effort and 5 vital questions

The Economist’s Future of Healthcare Insight Hour | Vaccine development: A race to the finish line

Devex | Q&A: Is COVID-19 helping or hindering progress toward an HIV vaccine?

TED | The trials, tribulations and timeline of a COVID-19 vaccine

Wired Korea | The End of World War C: Peace without Victory?

Asian Boss | World’s Leading Vaccine Expert Fact-Checks COVID-19 Vaccine Conspiracy

Development Today | Why Sweden funds a vaccine institute in Korea and not Oslo-based CEPI

CNBC | Parts of Asia that relaxed restrictions without a resurgence in coronavirus cases did these three things

The Korea Herald | [Herald Interview] ‘Making vaccines accessible is biggest COVID-19 challenge’

CGTN: The Agenda with Stephen Cole | Speed of vaccine trials is ‘unprecedented’

Asian Boss | We Asked The World’s Leading Vaccine Expert About COVID-19 Vaccine

The Guardian | Test, trace, contain: how South Korea flattened its coronavirus curve

BBC World Service: The Inquiry | How do we come out of the lockdown? (13:00)

ANC 24/7 | Int’l Vaccine Institute: 12-18 months reasonable timetable for development of Covid-19 vaccine

Seeker | How Fast Can We Make a Coronavirus Vaccine?

Education City Speaker Series: Flattening the Curve – Global Responses to COVID-19

Wion News | About 70% of vaccines used around the world are made in India: S Korean expert Dr Jerome Kim

South China Morning Post | How long will a coronavirus vaccine take? A Q&A with Jerome Kim, head of the International Vaccine Institute

BBC World News | Jerome Kim: Vaccines are the long-term solution to the pandemic

The Korea Times | Developing vaccine against COVID-19

TRT: Bigger than Five | COVID-19: The World Reacts

South Korea’s fight against coronavirus (CBS News)

NDTV | Top South Korea Doctor On Why He Thinks Coronavirus Is Not A ‘Chinese Virus’

RTE | What South Korea can teach Ireland about fighting Covid-19

Physical distancing should last months, not weeks, says epidemiologist (Yahoo News Canada)

Development of vaccine requires massive investment… international cooperation is needed (Korea Economic Daily)

COVID-19 Pandemic (Arirang TV, 22:50~46:00)

By then, we’ll have a vaccine on our side (Hankyoreh—Korean)

Coronavirus Pandemic: International Vaccine Institute director on how long it will take to develop vaccine (CGTN)

Testing times: Why South Korea’s COVID-19 strategy is working (Al Jazeera English)

Genexine seeks to compress the vaccine timeline

Genexine, Binex to develop COVID-19 vaccine (Korea Biomedical Review)

Genexine, Binex to co-develop coronavirus vaccine GX-19 (Korea Herald)

How close are we to a COVID-19 vaccine? Jerome H. Kim from International Vaccine Institute (Arirang News)

COVID-19 vaccine, drugs on fast track for development: IVI chief (Yonhap News)

Inside the race to find a coronavirus vaccine (Devex)

Chinese students keen for turnaround (China Daily)

China Daily | S. Korea can try out makeshift hospitals, experts say

Director General Jerome Kim for Phoenix TV

Speed and accuracy vital for COVID-19 test kits (Arirang News)

2020 COVID-19 Live Updates: Jerome Kim for tbs eFM

Jerome Kim for KBS WORLD Radio, Korea24 on the COVID-19 outbreak in South Korea

Korea should join efforts in vaccine development to prevent pandemics (JoongAng Ilbo)

Future global health threats

IVI: COVID-19 could linger (Korean)

Jerome Kim for Korea, Factual: “Hong Kong’s handling of COVID-19 outbreak & Prospects of vaccine development”

Concerns about the spread of COVID-19: When will a vaccine be developed? When can we expect the “Super Vaccine”?

Al Jazeera English | Scientists call for global cooperation over coronavirus

When will COVID-19 vaccine be commercialized…And “super vaccine”? (Korean)

Global push to find vaccine against devastating bug growing

IVI receives $15.7 million to conduct Ph III trials of typhoid vaccine

Korean vaccines expanding global territory

Neglected Victims of Neglected Diseases

Let’s build a common defense against epidemics

Vaccine investment brings 16-fold return… partnering with Bill Gates

World must join forces to prevent infectious diseases

IVI editorial in The Korea Herald advocates for Korean leadership for global health


Donor Spotlight: Lee Sang-hee & Friends

2016-10-10 07:21

Donor Spotlight: Lee Sang-hee & Friends

-Long-time IVI supporter and violinist Ms. Lee Sang-hee featured in the major Korean daily, JoongAng Ilbo
-Ms. Lee has been holding IVI charity concerts with her students for 12 years, raising close to $100,000
-Two Lee Sang-hee & Friends concerts in August and November this year

Below is an English translation of the JoongAng Ilbo article published on May 11, 2016.

‘I will continue performances to help others until the last day I can move my fingers’
- Lee Sang-hee continues holding charity concerts for 12th year to support vaccines for developing countries
- Targets 100 million won in cumulative donations in August 2016; ‘we will promote value of life-saving vaccines’



Lee Sang-hee and Friends at ‘Lee Sang Hee Violin Recital with IVI’

Violinist Lee Sang-hee’s performances are ‘life-saving jabs.’ She has continued holding charity concerts for 12 consecutive years, and donated the entire proceeds to IVI.

IVI is a non-profit international organization that develops and deploys vaccines against infectious diseases such as cholera. The cumulative total of donations through Lee Sang Hee Violinist Recital with IVI’ amounts to about 88 million won. Lee aims to surpass 100 million won through the upcoming concert in August.

“I wanted to inform audiences of how important a drop of vaccine is to saving lives, and to mobilize and amass pennies to help children in developing countries.” She told the reporter in an interview in Seoul on May 6. She said, “I decided to offer a benefit concert upon hearing for the first time stories about children who are suffering from infectious diseases while participating in an event as performer at an IVI donation event in 2004.”

After graduating from Sunhwa Middle and High Schools of Arts in Korea, she graduated from the Paris National Music Academy of Excellence (Conservatoire National Superieur Musique De Paris) in France with honors. She currently is teaching at Chung-Ang University graduate school, Sangmyung University, and Sunhwa schools. She married in 2006 and has a three-year-old daughter.

She started holding concert alone initially, but since 2007, has been holding joint performance in collaboration with ‘Lee Sang Hee & Friends.’ While studying in France, she formed the ensemble ‘Uni Song’ with fellow students from Korea, and held concerts to help a Korean adoptees organization for seven years.

These days, she is also holding charity concerts at hospitals, orphanages, correctional houses, and welfare facilities for single moms. She says her philanthropy was due to influence from her parents. “When I was young, my father, a businessman, would take me to orphanages, present dolls to children, and play with them. My father told me to ‘use your talent to benefit the world.”

‘Lee Sang Hee & Friends’ started with five members, but now has more than 30. “My students’ families and friends, and their friends joined us. There is no restriction in terms of age or performing skills. It is our (warm) heart that we want to convey and communicate onstage to audience members.”

There are members from all walks of life, ranging from 10-year-old pianist, to a performer close to age 70. Musical instruments include cello, flute, viola, clarinet, and others. All of the members, including a middle-school student who donated her ‘piggy bank’ from monthly allowances and a student who got into medical school to become doctor’ as a result of her activities for the concert, joined hands to help me.”

In the beginning, it was not easy to sell tickets for 600 seats in a concert hall. But she was able to expand her audience by performing popular songs, in addition to original classical music. “I wish to continue staging concerts to help others until the last day I can move my fingers,as well as now.”

“Lee Sang Hee Violin Recital with IVI’ will take place at 2 p.m. on August 27 at Youngsan Arts Hall in Seoul. Tickets are priced at 10,000 won to 30,000 per seat.